Full Press Release Details
Publication Date: September 26, 2024 Published By: Pharmacy Times Article Link: https://www.pharmacytimes.com/view/pharmacy-focus—oncology-edition-advancing-brain-cancer-research-and-treatment
Pharmacy Times’ Assistant Editor Kennedy Ferruggia sat down with Dr. Thomas Chen to discuss his work on NeOnc’s nasal delivery system for chemotherapeutics. In the podcast they examine how NeOnc, Inc. is developing innovative intranasal drug delivery methods to bypass the blood-brain barrier and treat brain cancers, including clinical trials for their lead candidate NEO100.
Pharmacy Times® is the industry-leading multimedia resource for community, health system, and specialty pharmacy news. With publications including the flagship Pharmacy Times as well as the partially peer-reviewed journals Pharmacy Practice in Focus: Oncology™ and Pharmacy Practice in Focus: Health Systems™, Pharmacy Times provides practical, clinical, and professional information that pharmacists can use in their day-to-day practice when counseling patients and partnering with other health care providers.
Dr. Thomas Chen, MD, PhD, has years of expertise in neurosurgery, spinal cancer, brain tumors, and medicine. Chen currently holds position of tenured Professor of Neurosurgery, Pathology, and Orthopedic Surgery at the Keck School of Medicine, University of Southern California. Chen is also the Founder and CEO of NeOnc, which focuses on developing therapeutics and drug delivery methods that treat central nervous system diseases and disorders.